G Aus

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Radical prostatectomy--long-term oncological outcome from a community hospital
    Maria Tol-Fakkar
    Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 37:376-81. 2003
  2. pmc A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
    Andrew J Vickers
    Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, East 63rd Street, New York, NY 10021, USA
    BMC Med 6:19. 2008
  3. ncbi request reprint Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, 413 45, Goteborg, Sweden
    Eur Urol 43:627-31. 2003
  4. ncbi request reprint Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 37:466-70. 2003
  5. ncbi request reprint Prostate biopsy and anaesthesia: an overview
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 39:124-9. 2005
  6. ncbi request reprint Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Cancer 103:943-51. 2005
  7. pmc Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Arch Intern Med 165:1857-61. 2005
  8. ncbi request reprint Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Eur Urol 51:659-64. 2007
  9. ncbi request reprint Current status of HIFU and cryotherapy in prostate cancer--a review
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, SE 413 45 Goteborg, Sweden
    Eur Urol 50:927-34; discussion 934. 2006
  10. ncbi request reprint Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
    G Aus
    Department of Urology, Ryhov Hospital, Jonkoping, Sweden
    BJU Int 90:561-6. 2002

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Radical prostatectomy--long-term oncological outcome from a community hospital
    Maria Tol-Fakkar
    Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 37:376-81. 2003
    ..The aim of this study is to report the oncological outcome at intermediate- to long-term follow-up after radical prostatectomy performed in a community hospital...
  2. pmc A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
    Andrew J Vickers
    Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, East 63rd Street, New York, NY 10021, USA
    BMC Med 6:19. 2008
    ..We set out to determine whether a multivariable model including four kallikrein forms (total, free, and intact PSA, and human kallikrein 2 (hK2)) could predict prostate biopsy outcome in previously unscreened men with elevated total PSA...
  3. ncbi request reprint Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, 413 45, Goteborg, Sweden
    Eur Urol 43:627-31. 2003
    ..It is difficult to give prognostic information based on the present literature. The aim of this study was to evaluate the impact of known risk factors in patients with pelvic node involvement and without distant metastasis...
  4. ncbi request reprint Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 37:466-70. 2003
    ..To evaluate whether the free-to-total prostate-specific antigen (F/T-PSA) ratio can be used to differentiate between stage pT2 and pT3 prostate cancer...
  5. ncbi request reprint Prostate biopsy and anaesthesia: an overview
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 39:124-9. 2005
    ..To evaluate the efficacy of different methods for decreasing pain and discomfort in men undergoing transrectal ultrasound-guided prostate biopsies and to propose a clinical standard useful for pain relief...
  6. ncbi request reprint Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Cancer 103:943-51. 2005
    ..To decide on screening strategies and curative treatments for prostate carcinoma, it is necessary to determine the incidence and survival in a population that is not screened...
  7. pmc Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Arch Intern Med 165:1857-61. 2005
    ....
  8. ncbi request reprint Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Eur Urol 51:659-64. 2007
    ..The aim of the present report is to evaluate whether PSA-based screening reduces the risk of being diagnosed with metastatic prostate cancer...
  9. ncbi request reprint Current status of HIFU and cryotherapy in prostate cancer--a review
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, SE 413 45 Goteborg, Sweden
    Eur Urol 50:927-34; discussion 934. 2006
    ..To evaluate the current status of high-intensity focused ultrasound (HIFU) and cryosurgery as the primary treatment option in patients with prostate cancer...
  10. ncbi request reprint Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
    G Aus
    Department of Urology, Ryhov Hospital, Jonkoping, Sweden
    BJU Int 90:561-6. 2002
    ..e. provide greater potential to completely excise the tumour)...
  11. ncbi request reprint Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study
    Gunnar Aus
    Department of Urology, Sahlgrenska University Hospital, S 41345, Goteborg, Sweden
    Eur Urol 42:133-8. 2002
    ..To study the complications and oncological outcome after cryosurgical ablation of the prostate (CSAP)...
  12. ncbi request reprint Editorial comment on: Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Eur Urol 52:1043. 2007
  13. doi request reprint The European Association of Urology (EAU) guidelines methodology: a critical evaluation
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Eur Urol 56:859-64. 2009
    ..Guidelines can be produced and written in numerous ways. The aim of the present article is to describe and evaluate the method currently used to produce the European Association of Urology (EAU) guidelines...
  14. ncbi request reprint Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, S41345 Göteborg, Sweden
    Eur Urol 45:160-5. 2004
    ..To evaluate the cumulative risk of having a prostate cancer diagnosis in a repeated screening situation in relation to the free-to-total prostate specific antigen ratio (F/T-PSA)...
  15. ncbi request reprint Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
    G Ahlgren
    Department of Urology, Lund University, University Hospital, Malmo, Sweden
    Prostate 42:274-9. 2000
    ..We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment...
  16. ncbi request reprint Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order
    G Aus
    Section of Urology, Ryhov Hospital, Jonkoping, Sweden
    Eur Urol 39:655-60; discussion 661. 2001
    ..The aim of this study was to evaluate the cancer detection rate of six systemic prostate biopsies with mid lobar biopsies taken far laterally in the prostate...
  17. ncbi request reprint Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
    J Hugosson
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    BJU Int 92:39-43. 2003
    ....
  18. ncbi request reprint Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening
    Björn Zackrisson
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Eur Urol 43:327-32. 2003
    ..To study the follow-up of men with elevated prostate-specific antigen (PSA) (>3 ng/ml) after one benign set of sextant biopsies. From the Göteborg branch of the European Randomised Study of Screening for Prostate Cancer (ERSPC)...
  19. doi request reprint Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees
    Anna Grenabo Bergdahl
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Cancer 115:5672-9. 2009
    ..Who dies from prostate cancer despite participation in a population-based prostate-specific antigen (PSA) screening program?..
  20. doi request reprint PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
    David Robinson
    Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Urology 72:903-7. 2008
    ..To assess the value of prostate-specific antigen (PSA) kinetics in predicting survival and relate this to the baseline variables in men with metastatic hormone-refractory prostate cancer (HRPC)...
  21. ncbi request reprint Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden
    Eur J Cancer 43:2109-16. 2007
    ..0001) and with increasing age (p=0.0016). Anxiety associated with prostate cancer screening in general is low to moderate, even in men with elevated PSA, and severe anxiety affects a smaller group of susceptible men...
  22. doi request reprint Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trial
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 184:984-9. 2010
    ..After radical retropubic prostatectomy a postoperative inguinal hernia develops in 15% to 20% of patients. We investigated whether a simple prophylactic procedure during radical retropubic prostatectomy would reduce this incidence...
  23. ncbi request reprint PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section
    Ali Khatami
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Int J Cancer 120:170-4. 2007
    ..In younger men with a PSADT of less than 4 years, surveillance does not seem to be a justified alternative, and patient should be informed about the risk with such an approach...
  24. ncbi request reprint Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
    Jonas Hugosson
    Department of Urology, Sahlrenska University Hospital, Gothenburg, Sweden
    Cancer 100:1397-405. 2004
    ..The purpose of the current study was to evaluate the effectiveness of a prostate carcinoma screening program in which serum prostate-specific antigen (PSA) levels were measured...
  25. ncbi request reprint Single-dose orally administered quinolone appears to be sufficient antibiotic prophylaxis for radical retropubic prostatectomy
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Urol Nephrol 38:143-7. 2004
    ..To evaluate a new prophylaxis routine, which was introduced at our clinic in December 1998, comprising a single oral dose of antibiotic given prior to radical retropubic prostatectomy (RRP)...
  26. doi request reprint Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
    Jonas Hugosson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden
    Lancet Oncol 11:725-32. 2010
    ..One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate...
  27. ncbi request reprint The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
    Bjørn Zackrisson
    Departments of Urology and Pathology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 171:1500-3. 2004
    ..We evaluated the significance of focal prostate cancer found in sextant biopsies in men participating in a biennial prostate specific antigen (PSA) based screening program...
  28. doi request reprint Prostate cancer
    Jan Erik Damber
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Lancet 371:1710-21. 2008
    ....
  29. ncbi request reprint Selective urological evaluation in men with febrile urinary tract infection
    P Ulleryd
    Department of Infectious Diseases, Sahlgrenska University Hospital, Goteborg, Sweden
    BJU Int 88:15-20. 2001
    ..To investigate the prevalence and clinical importance of urological abnormalities in men with community-acquired febrile urinary tract infection (UTI)...
  30. ncbi request reprint EAU guidelines on prostate cancer
    G Aus
    Department of Urology, Ryhov Hospital, Jonkoping, Sweden
    Eur Urol 40:97-101. 2001
    ..To develop clinical guidelines for the management of patients with prostate cancer...
  31. ncbi request reprint Treatment of patients with clinical T3 prostate cancer
    G Aus
    Department of Urology, Ryhov Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 36:28-33. 2002
    ..To describe and evaluate treatment alternatives for patients with clinical T3 prostate cancer...
  32. ncbi request reprint Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection
    Björn Zackrisson
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Urology 62:278-81. 2003
    ..To determine the serum values of free, complexed, and total prostate-specific antigen (PSA) and their ratios in men with febrile urinary tract infection (UTI) during 1 year of follow-up...
  33. ncbi request reprint Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable
    Jonas Hugosson
    Department of Urology, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden
    J Urol 169:1720-3. 2003
    ..We evaluated whether biennial screening with prostate specific antigen (PSA) only is sufficient to detect prostate cancer while still curable...
  34. ncbi request reprint [Brachytherapy with palladium-103--a new way to deliver radiation therapy for localized prostatic cancer]
    G Aus
    Dept of Urology, Lanssjukhuset Ryhov, Jonkoping, Sweden
    Lakartidningen 97:3470-4. 2000
    ..The procedure, indications, contraindications, side effects and results from the literature 28 patients have been treated so far with acceptable proximate side effects and reductions in serum-PSA as expected...
  35. ncbi request reprint Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors
    David Robinson
    Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 41:103-9. 2007
    ..To evaluate the disease-specific mortality of conservatively managed incidental carcinoma of the prostate (T1a and T1b) in relation to prognostic factors...
  36. ncbi request reprint Erectile function outcome reporting after clinically localized prostate cancer treatment
    Arthur L Burnett
    The Johns Hopkins Hospital, 600 North Wolfe St, Marburg 407, Baltimore, Maryland 21287 2411, USA
    J Urol 178:597-601. 2007
    ....
  37. ncbi request reprint Guideline for the management of clinically localized prostate cancer: 2007 update
    Ian Thompson
    American Urological Association Education and Research, Inc
    J Urol 177:2106-31. 2007
  38. ncbi request reprint Second-line therapy after radical prostatectomy failure: for whom? When? How?
    Gunnar Aus
    Eur Urol 51:1155-7; discussion 1157-8. 2007
  39. doi request reprint Cryosurgery for prostate cancer
    Gunnar Aus
    J Urol 180:1882-3. 2008
  40. ncbi request reprint Men's perception of fatigue when newly diagnosed with localized prostate cancer
    Annikki Jonsson
    Department of Primary Care, Höglandssjukhuset, Nassjo, Sweden
    Scand J Urol Nephrol 41:20-5. 2007
    ....
  41. ncbi request reprint Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the re
    Michael S Cookson
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    J Urol 177:540-5. 2007
    ....
  42. ncbi request reprint Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors
    Lars Henningsohn
    Department of Oncology, Radiumhemmet, Z 6, Karolinska Institute, Box 4402, S 102 68, Stockholm, Sweden
    Eur Urol 43:651-62. 2003
    ..Little is known about this variation in urinary bladder cancer survivors (in other words, about the relative importance of sources of symptom-induced distress)...
  43. ncbi request reprint EAU guidelines on prostate cancer
    Axel Heidenreich
    Department of Urology, University Hospital Cologne, Cologne, Germany
    Eur Urol 53:68-80. 2008
    ..To present a summary of the 2007 version of the European Association of Urology (EAU) guidelines on prostate cancer (PCa)...